Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Maravai LifeSciences Holdings, Inc. MRVI
$14.47
+$0.82 (5.70%)
На 18:03, 12 мая 2023
+62.40%
Потенциал через год
Ранг: 1
Ключевые показатели
-
Marketcap
3012872029.00000000
-
week52high
35.82
-
week52low
11.89
-
Revenue
883001000
-
P/E TTM
4
-
Beta
-0.23462400
-
EPS
1.69000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 20:00
Описание компании
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | 08 авг 2022 г. |
| Goldman Sachs | Buy | Buy | 14 июл 2022 г. |
| Morgan Stanley | Overweight | Overweight | 09 мая 2022 г. |
| Keybanc | Overweight | Overweight | 06 мая 2022 г. |
| Morgan Stanley | Overweight | Overweight | 25 февр 2022 г. |
| Credit Suisse | Outperform | 25 авг 2022 г. | |
| Keybanc | Overweight | Overweight | 03 ноя 2022 г. |
| Credit Suisse | Outperform | Outperform | 03 ноя 2022 г. |
| B of A Securities | Neutral | Buy | 03 ноя 2022 г. |
| Morgan Stanley | Overweight | Overweight | 04 ноя 2022 г. |
| Goldman Sachs | Buy | Buy | 04 ноя 2022 г. |
| UBS | Neutral | Buy | 05 янв 2023 г. |
| Deutsche Bank | Buy | 14 дек 2022 г. | |
| RBC Capital | Outperform | 07 дек 2022 г. | |
| Goldman Sachs | Buy | Buy | 17 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| GTCR INVESTMENT XI LLC | D | 119094026 | 4575170 | 22 янв 2023 г. |
| GTCR INVESTMENT XI LLC | D | 119094026 | 4575170 | 22 янв 2023 г. |
| NEEL BRIAN | A | 18785 | 329 | 31 окт 2022 г. |
| ORESHACK KURT | A | 26282 | 351 | 31 окт 2022 г. |
| Herde Kevin | A | 21294 | 478 | 31 окт 2022 г. |
| MARTIN WILLIAM E. III | A | 240038 | 240038 | 17 окт 2022 г. |
| MARTIN WILLIAM E. III | A | 403946 | 403946 | 17 окт 2022 г. |
| MARTIN WILLIAM E. III | A | 348055 | 228036 | 17 окт 2022 г. |
| MARTIN WILLIAM E. III | A | 120019 | 120019 | 17 окт 2022 г. |
| Leddy Peter Michael | A | 122893 | 122893 | 15 июл 2022 г. |
Новостная лента
Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023
GlobeNewsWire
01 февр 2023 г. в 08:00
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2022 financial and operating results after the market closes on Wednesday, February 22, 2023, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
3 Great Growth Stocks Down 20% or More to Buy Now
The Motley Fool
27 янв 2023 г. в 09:37
These beaten-down stocks could be poised for major rebounds.
3 Biopharma Stocks That Could Help Make You a Fortune
The Motley Fool
16 янв 2023 г. в 08:30
All three are protected by sales of in-demand products, with more on the way.
These Were The Five Best And Worst Performing Mid-Cap Stocks In October 2022
24/7 Wall Street
15 ноя 2022 г. в 20:22
Mid-cap companies lie in between the slower growth large-cap stocks and the faster-growth small-cap businesses.
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2022 Earnings Call Transcript
Seeking Alpha
02 ноя 2022 г. в 22:56
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q3 2022 Results Conference Call November 2, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Interim Chief Executive Officer Kevin Herde - Chief Financial Officer Conference Call Participants Tejas Savant - Morgan Stanley John Sourbeer - UBS Paul Knight - KeyBanc Madeline Mollman - William Blair Michael Ryskin - Bank of America Dan Arias - Stifel Dan Leonard - Credit Suisse Brandon Couillard - Jefferies Operator Greetings, and welcome to Maravai LifeSciences Third Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.